Pure Global
PACTR201808699550182

Monobenzyl Ether of Hydroquinone in Depigmentation of Vitiligo.

Monobenzyl Ether of Hydroquinone (MBEH) 20% and 40% Cream in Depigmentation of Vitiligo Patients: Randomized controlled trial.
Vitiligo unit Dermatology department Cairo university·Phase 4·Pan Africa Clinical Trials Registry·drugCompleted
Study focus
Disease/Condition
Skin and Connective Tissue Diseases
Intervention type
drug
Sponsor & location
Primary sponsor
Vitiligo unit Dermatology department Cairo university
Location
Egypt
Timeline & enrollment
Phase
Phase 4
Start date
Nov 30, 2016
End date
May 30, 2018
Summary

Background: Depigmentation presents a final alternative for patients with widespread vitiligo, failing to attain satisfactory pigmentation and having a compromised quality of life (QOL). Monobenzyl Ether of Hydroquinone (MBEH) is the most widely used topical preparation for depigmentation but little is known regarding specific features of its utilization. Objective: Evaluating and comparing two concentrations of MBEH cream (20% & 40%) regarding their efficacy, tolerability and effect on patients’ QOL.

ICD-10 classifications
Systemic disorders of connective tissue in diseases classified elsewhereSystemic disorders of connective tissue in other diseases classified elsewhereDiseases of the skin and subcutaneous tissueOther disorders of skin and subcutaneous tissue in diseases classified elsewhereOther disorders of the skin and subcutaneous tissue
Data source
Registry
Pan Africa Clinical Trials Registry
Trial ID
PACTR201808699550182
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for PACTR201808699550182 through Pure Global AI's free database. This Phase 4 trial is sponsored by Vitiligo unit Dermatology department Cairo university and is currently Completed. The study focuses on Skin and Connective Tissue Diseases.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.